Article Information
History
- September 18, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Christopher J. R. Illingworth1,2,*,†,
- Alexandra Y. Kreins3,4,*,
- Adriana Margarit-Soler3,
- Tim Best3,
- Patricia Dyal4,
- Giovanna Lucchini3,
- Kanchan Rao3,
- Rachel Williams4,
- Austen Worth3 and
- Judith Breuer3,4
- 1MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom
- 2Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, United Kingdom
- 3Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
- 4Infection, Immunity and Inflammation Research and Teaching Department, University College London, London, UK
- ↵†Email: christopher.illingworth{at}glasgow.ac.uk
↵* Authors contributed equally
Posted September 18, 2022.
Within-host virus evolution during the extended treatment of RSV infection with mutagenic drugs
